Recombinant monoclonal antibody against mouse and human CXCL12α, CXCL12β, and CXCL12γ, was shown to dose-dependently block CXCL12α binding to CXCR4 and CXCR7, and CXCL12α-induced Jurkat cell migration in vitro.
Figure 1 In vivo activity of hu30D8.
Dose-dependent efficacy of hu30D8 in the human Calu-6 tumor model. Balb c/nude mice (n = 10/group) were treated with hu30D8 at various doses, alone) or with 30 mg/kg hu30D8 in combination with 10 mg/kg B20.4.1.1. Tumor size was measured at day 7, 10, 14, 17, and 21.
Zhong, C., Wang, J., Li, B., Xiang, H., Ultsch, M., Coons, M., ... & Quintana, L. (2013). Development and preclinical characterization of a humanized antibody targeting CXCL12. Clinical Cancer Research, 19(16), 4433-4445.
Figure 2 In vivo activity of hu30D8.
Percentage of F4/80+, CD11b+/Gr1+, and CD31+ cells in Calu6 tumors treated with the control human antibody or hu30D8 at day 21 after tumor cell implantation using FACS. Data are expressed as means ± SD and are representative of 3 independent experiments.
Zhong, C., Wang, J., Li, B., Xiang, H., Ultsch, M., Coons, M., ... & Quintana, L. (2013). Development and preclinical characterization of a humanized antibody targeting CXCL12. Clinical Cancer Research, 19(16), 4433-4445.
Figure 3 Pharmacokinetic profiles of hu30D8.
hu30D8 e serum concentration–time profiles in cynomolgus monkeys after a single intravenous administration at 30 mg/kg (n = 5/group). Sera were collected for up to 10 days.
Zhong, C., Wang, J., Li, B., Xiang, H., Ultsch, M., Coons, M., ... & Quintana, L. (2013). Development and preclinical characterization of a humanized antibody targeting CXCL12. Clinical Cancer Research, 19(16), 4433-4445.
Figure 4 Pharmacokinetic profiles of hu30D8.
hu30D8 serum concentration showed in and was measured by a specific ELISA using human CXCL12α as a coating agent.
Zhong, C., Wang, J., Li, B., Xiang, H., Ultsch, M., Coons, M., ... & Quintana, L. (2013). Development and preclinical characterization of a humanized antibody targeting CXCL12. Clinical Cancer Research, 19(16), 4433-4445.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-256-F(E) | Recombinant Anti-human CXCL12 Antibody Fab Fragment | IF, FACS, FuncS | Fab |
MHH-256-F(E) | Recombinant Human Anti-human CXCL12 Antibody Fab Fragment | WB, ELISA, FuncS | Fab |
PFBL-057 | Human Anti-CXCL12 Recombinant Antibody; Fab Fragment (PFBL-057) | FC, ELISA, FuncS | Human Fab |
HPAB-0050LY-F(E) | Human Anti-CXCL12 Recombinant Antibody; Fab Fragment (HPAB-0050LY-F(E)) | Block, ELISA, WB, RIA, FC | Human Fab |
HPAB-0051LY-F(E) | Human Anti-CXCL12 Recombinant Antibody; Fab Fragment (HPAB-0051LY-F(E)) | Block, ELISA, WB, RIA, FC | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-256-S(P) | Recombinant Anti-human CXCL12 Antibody scFv Fragment | IP, IF, Biosensors, FuncS | scFv |
MHH-256-S(P) | Recombinant Human Anti-human CXCL12 Antibody scFv Fragment | ELISA, WB, IF, FuncS | scFv |
HPAB-0050LY-S(P) | Human Anti-CXCL12 Recombinant Antibody; scFv Fragment (HPAB-0050LY-S(P)) | Block, ELISA, WB, RIA, FC | Human scFv |
HPAB-632-FY-S(P) | Mouse Anti-CXCL12 Recombinant Antibody; scFv Fragment (HPAB-632-FY-S(P)) | Inhib | Mouse scFv |
HPAB-633-FY-S(P) | Mouse Anti-CXCL12 Recombinant Antibody; scFv Fragment (HPAB-633-FY-S(P)) | Block | Mouse scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
NABG-040 | Recombinant Anti-Human CXCL12 VHH Single Domain Antibody | WB, ELISA, IHC, FuncS | Llama VHH |
HPAB-0348-YC-VHH | Llama Anti-CXCL12 Recombinant Antibody; VHH Fragment (HPAB-0348-YC-VHH) | FuncS | Llama VHH |
CAT | Product Name | Application | Type |
---|---|---|---|
PABL-057 | Human Anti-CXCL12 Recombinant Antibody (PABL-057) | FC, ELISA, FuncS | Human IgG |
MOB-1847CT | Recombinant Mouse anti-Human CXCL12 Monoclonal antibody (NN0322-0O37) | FC, IHC-P | |
HPAB-0050LY | Human Anti-CXCL12 Recombinant Antibody (HPAB-0050LY) | Block, ELISA, WB, RIA, FC | Human IgG1 |
HPAB-0051LY | Human Anti-CXCL12 Recombinant Antibody (HPAB-0051LY) | Block, ELISA, WB, RIA, FC | Human IgG1 |
HPAB-0052LY | Human Anti-CXCL12 Recombinant Antibody (HPAB-0052LY) | Block, ELISA, WB, RIA, FC | Human IgG1 |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-415CT | Anti-Human CXCL12 Recombinant Antibody (30D8) | Inhib, WB, FC, Funcs, ELISA, Neut | |
TAB-415CT-S(P) | Anti-Human CXCL12 Recombinant Antibody scFv Fragment (30D8) | WB, ELISA, Neut, FC | |
TAB-415CT-F(E) | Anti-Human CXCL12 Recombinant Antibody Fab Fragment (30D8) | WB, ELISA, Neut, FC |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-416CT-S(P) | Anti-Human CXCL12 Recombinant Antibody scFv Fragment (hu30D8) | WB, ELISA, Neut, FC | Humanized antibody |
TAB-416CT-F(E) | Anti-Human CXCL12 Recombinant Antibody Fab Fragment (hu30D8) | WB, ELISA, Neut, FC | Humanized antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-417CT-S(P) | Human Anti-CXCL12 Recombinant Antibody; scFv Fragment (TAB-417CT-S(P)) | BL, WB, ELISA | Human scFv |
TAB-418CT-S(P) | Human Anti-CXCL12 Recombinant Antibody; scFv Fragment (TAB-418CT-S(P)) | BL, WB, ELISA | Human scFv |
TAB-419CT-S(P) | Human Anti-CXCL12 Recombinant Antibody; scFv Fragment (TAB-419CT-S(P)) | BL, WB, ELISA | Human scFv |
TAB-420CT-S(P) | Human Anti-CXCL12 Recombinant Antibody; scFv Fragment (TAB-420CT-S(P)) | BL, WB, ELISA | Human scFv |
TAB-417CT-F(E) | Human Anti-CXCL12 Recombinant Antibody; Fab Fragment (TAB-417CT-F(E)) | BL, WB, ELISA | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-612CQ | Mouse Anti-CXCL12 Recombinant Antibody (clone CBL825) | Neut | Mouse IgG1 |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-0884 | Hi-Affi™ Rabbit Anti-CXCL12 Recombinant Antibody (clone DS884AB) | WB, ICC, IF | Rabbit IgG |
There are currently no Customer reviews or questions for TAB-416CT. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.